Department of Medicinal Chemistry, Nanjing University of Chinese Medicine, Nanjing, China.
Drug Dev Res. 2020 Apr;81(2):206-214. doi: 10.1002/ddr.21585. Epub 2019 Aug 9.
The proteolytic enzyme β-secretase (BACE1) plays a central role in the synthesis of the pathogenic β-amyloid peptides (Aβ) in Alzheimer's disease (AD), antioxidants could attenuate the AD syndrome and prevent the disease progression. In this study, BACE1 inhibitors (D1-D18) with free radical-scavenging activities were synthesized by molecular hybridization of 2-aminopyridine with natural antioxidants. The biological activity evaluation showed that D1 had obvious inhibitory activity against BACE1, and strong antioxidant activity in 1,1-diphenyl-2-picrylhydrazyl (DPPH) and 2,2'-azinobis-(3-ethylbenzthiazoline-6-sulphonate) (ABTS ) assay, which could be used as a lead compound for further study.
β-分泌酶(BACE1)是阿尔茨海默病(AD)中致病β-淀粉样肽(Aβ)合成的关键酶,抗氧化剂可以减轻 AD 综合征并阻止疾病进展。在这项研究中,通过将 2-氨基吡啶与天然抗氧化剂进行分子杂交,合成了具有自由基清除活性的 BACE1 抑制剂(D1-D18)。生物活性评价表明,D1 对 BACE1 具有明显的抑制活性,并且在 1,1-二苯基-2-苦基肼(DPPH)和 2,2'-联氮双-(3-乙基苯并噻唑啉-6-磺酸)(ABTS)测定中具有很强的抗氧化活性,可作为进一步研究的先导化合物。